Cinclus Pharma participates at RedEye Investor Forum in Gothenburg
Christer Ahlberg, CEO of Cinclus Pharma, will participate at Redeye Investor Forum in Gothenburg October 9th, where he will present the company and the development of linaprazan glurate.